Credit: Arcutis. The approval was supported by data from 2 randomized, double-blind, vehicle-controlled trials that included 736 patients aged 12 years and older with mild to severe plaque psoriasis ...

Phase 3 ONWARD3 data demonstrate sustained skin clearance, pruritus relief, and quality of life improvements with ...

Results build on ONWARD3 highest complete skin clearance (54% PASI 100) at Week 48, reinforcing envudeucitinib’s potential to become a leading ...

Medically reviewed by Leah Ansell, MDMedically reviewed by Leah Ansell, MD Plaque psoriasis is the most common type of psoriasis. Plaques are pink/red, raised, thick, inflamed skin patches covered by ...

Arcutis Biotherapeutics has received FDA approval for ZORYVE (roflumilast) topical foam 0.3%, which is now available for treating plaque psoriasis on the scalp and body in patients aged 12 and older.

Once-daily oral icotrokinra produced sustained plaque psoriasis control through week 112, including scalp, genital, palmoplantar, and nail improvements, without new safety signals. Zasocitinib 30 mg ...

Plaque PsO is an immune-mediated disease resulting in the overproduction of skin cells, which causes inflamed, scaly plaques that may be itchy or painful. It is estimated that eight million Americans ...

Icotrokinra was safe and effective for improving skin clearance among patients with skin, scalp, and/or genital psoriasis. Icotrokinra (ICO) significantly improves skin clearance and reduces psoriasis ...

Courtney is a registered nurse with over 13 years of experience in the clinical setting, helping individuals navigate their way through their healthcare journeys. She has been in the frontlines ...

Psoriasis causes thick patches of skin called plaques that are dry and flaky. Dandruff usually comes and goes and can be caused by oily hair or irritants. Psoriasis is a chronic autoimmune disease and ...

Johnson & Johnson (NYSE: JNJ) today announced new two-year data from the Phase 3 ICONIC-TOTALa study demonstrating the positive impact ...

Alisha Bridges, 36, knows what it feels like to be treated differently because of how she looks. Since elementary school, Alisha has struggled with severe plaque psoriasis—a condition which causes ...